Patent · US Active

Pentacyclic triterpenoid compound with modified structure and preparation method and use thereof

US9725482B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 18, 2014
Grant dateAug 8, 2017
Priority date
Expiry dateNov 18, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to new pentacyclic triterpenes, their preparation method and use. The compounds of the present invention could effectively treat psoriasis and selectively inhibit in vitro differentiation of the TH1 and TH17 cells, thereby could be used to treat the TH1- or TH17-mediated autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.